Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
1.840
-0.010 (-0.54%)
Jun 20, 2024, 12:36 PM EDT - Market open

Alterity Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Year
20232022202120202019 2018 - 2000
Net Income
-13.81-12.85-15.31-13.46-12.34
Upgrade
Other Operating Activities
-6.230.51-2.024.03-1.62
Upgrade
Operating Cash Flow
-20.04-12.34-17.33-9.43-13.95
Upgrade
Capital Expenditures
-0.01-0.09-0.01-0.02-0.01
Upgrade
Other Investing Activities
-0.03----
Upgrade
Investing Cash Flow
-0.04-0.09-0.01-0.02-0.01
Upgrade
Share Issuance / Repurchase
0.3217.1839.244.3613.08
Upgrade
Debt Issued / Paid
-0.06-0.03-0.06-0.090
Upgrade
Other Financing Activities
-0.13-0.84-2.49-0.29-0.36
Upgrade
Financing Cash Flow
0.1216.336.693.9812.72
Upgrade
Exchange Rate Effect
0.912.81-0.430.260.4
Upgrade
Net Cash Flow
-19.953.8819.35-5.47-1.24
Upgrade
Free Cash Flow
-20.04-12.43-17.34-9.45-13.96
Upgrade
Free Cash Flow Per Share
-4.95-3.10-6.13-6.33-13.60
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).